• Explore /
  • Poster
  • / Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery.

Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery.

Abstract Poster

Authors

Sakti Chakrabarti

Sakti Chakrabarti

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH

Sakti Chakrabarti , Stacey A. Cohen , Antony Tin , Autumn Dangl , Vasily N. Aushev , Mohamedtaki Abdulaziz Tejani , Sreenivasa R Chandana , Midhun Malla , Ron G. Landmann , Vivek R. Sharma , Gregory P. Botta , Arun Nagarajan , Georges Azzi , May Thet Cho , Farshid Dayyani , Diana L. Hanna , Adham A Jurdi , Minetta C. Liu , Arvind Dasari , Pashtoon Murtaza Kasi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 212)

DOI

10.1200/JCO.2024.42.3_suppl.212

Abstract #

212

Poster Bd #

M20

Abstract Disclosures

Similar Posters

First Author: Abhineet Uppal

First Author: Glenn J. Hanna

First Author: Giacomo Bregni

First Author: Yinyin Chang